Geo-linked system to find and respond to antimalarial drug resistance in Ghana

Geo-enabled detect and respond system for antimalarial resistance in Ghana: GDRS - Ghana

NIH-funded research Institute of Human Virology · NIH-11416246

This project will use small community blood samples and GPS-linked data in Ghana to spot early signs of malaria parasites becoming resistant to antimalarial drugs so treatments keep working.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionInstitute of Human Virology NIH-funded
Lab location1 site (Abuja, Nigeria)
Project IDNIH-11416246 on NIH RePORTER

What this research studies

You may be asked to give a small finger-prick dried blood spot and basic location or community information for surveillance. Teams will link each sample to GPS-based location data and send samples to regional genomic labs in a hub-and-spoke network for molecular testing of malaria parasites. The project combines those genomic results with local health and survey data to map where drug-resistant parasites are emerging. That information is shared with health authorities to guide treatment choices and public health responses.

Who could benefit from this research

Good fit: Ideal participants are community members in the Ghanaian areas covered by the project who can provide a small dried blood spot and basic location/contact information, including people with recent malaria or for routine community surveillance.

Not a fit: People living outside the surveillance regions or those not infected with malaria are unlikely to receive direct benefits from this surveillance project.

Why it matters

Potential benefit: If successful, this could help health officials detect drug-resistant malaria sooner and change treatments to prevent more people from having ineffective therapy.

How similar studies have performed: Molecular surveillance using parasite genetic markers has helped detect resistance in other regions and is increasingly used, though combining community GPS-linked sampling with expanded hub-and-spoke genomic networks is a newer, expanding approach.

Where this research is happening

Abuja, Nigeria

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.